Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2010 - 2026)

Pacific Biosciences Of California's Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $48.2 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 57.47% year-over-year to $48.2 million; the TTM figure through Mar 2026 stood at $274.9 million (up 2158.87% YoY), while the FY2025 annual figure was $340.1 million, up 875.65% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $48.2 million, down from $60.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $320.1 million in Q3 2023, with the low at -$445.6 million in Q4 2024.
• The 4-year median for Change in Acquisitions & Divestments is $128.8 million (2024), against an average of $91.7 million.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments slumped 422.26% in 2024, then soared 113.46% in 2025.
• Pacific Biosciences Of California's Change in Acquisitions & Divestments stood at $138.3 million in 2023, then plunged by 422.26% to -$445.6 million in 2024, then surged by 113.46% to $60.0 million in 2025, then dropped by 19.56% to $48.2 million in 2026.
• Business Quant data shows PACB's Change in Acquisitions & Divestments at $48.2 million in Q1 2026, $60.0 million in Q4 2025, and $84.6 million in Q3 2025.